Scripps Cardiologist Weighs in on Statin Debate

Cholesterol-lowering statins might be doing more harm than good in some patients, Scripps Health Chief Academic Officer Eric Topol, MD cautioned in a March 4 Op-Ed article in the New York Times. He called for more research into the relationship between the drugs and higher rates of diabetes. Dr. Topol also weighed in on combination therapies that mix statins with other cholesterol-lowering drugs in a March 6 New York Times article.

Read the full articles here:

New York Times – March 4
New York Times – March 6